ArticleOncotarget2018

Differential genomics and transcriptomics between tyrosine kinase inhibitor-sensitive and -resistant BCR-ABL-dependent chronic myeloid leukemia.

Neetu Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.